Ustekinumab Matches TNF Inhibitors for PsA in Real-World Study Ustekinumab Matches TNF Inhibitors for PsA in Real-World Study

A real-world study comparing the interleukin-12/23 inhibitor ustekinumab with tumor necrosis factor inhibitors for psoriatic arthritis found similar rates of treatment persistence and efficacy.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news